COVID-19 took a heavy toll on Medtronic's most recent fiscal quarter, but given the company's strong pipeline and balance sheet, the company could emerge from the pandemic stronger than ever.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,